Profound Medical Corp. (PROF) SEC filings

PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$7.85+0.17 (+2.21%)

Close on Nov 11, 2026Market cap $286.78MP/E –Yield –

SEC filings

40 of Profound Medical's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Nov 5, 2026	Nov 12, 2026	SEC EDGAR
Current report	8-K	Nov 9, 2026	Nov 9, 2026	SEC EDGAR
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Oct 28, 2026	Nov 3, 2026	SEC EDGAR
Current report	8-K	Oct 22, 2026	Oct 22, 2026	SEC EDGAR
Current report	8-K	Oct 14, 2026	Oct 14, 2026	SEC EDGAR
Current report	8-K	Oct 9, 2026	Oct 9, 2026	SEC EDGAR
Current report	8-K	Oct 7, 2026	Oct 7, 2026	SEC EDGAR
Current report	8-K	Sep 3, 2026	Sep 4, 2026	SEC EDGAR
Current report	8-K	Sep 1, 2026	Sep 3, 2026	SEC EDGAR
Current report	8-K	Aug 17, 2026	Aug 17, 2026	SEC EDGAR
Current report	8-K	Aug 14, 2026	Aug 17, 2026	SEC EDGAR
Current report	8-K	Aug 13, 2026	Aug 13, 2026	SEC EDGAR
Current report	8-K	Aug 6, 2026	Aug 6, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Jul 24, 2026	Jul 24, 2026	SEC EDGAR
Current report	8-K	Jul 16, 2026	Jul 16, 2026	SEC EDGAR
Current report	8-K	Jul 15, 2026	Jul 15, 2026	SEC EDGAR
Current report	8-K	May 13, 2026	May 15, 2026	SEC EDGAR
Current report	8-K	May 14, 2026	May 14, 2026	SEC EDGAR
Current report	8-K	May 7, 2026	May 7, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 7, 2026	SEC EDGAR
Current report	8-K	Apr 16, 2026	Apr 16, 2026	SEC EDGAR
Current report	8-K	Apr 14, 2026	Apr 14, 2026	SEC EDGAR
Current report	8-K	Apr 1, 2026	Apr 1, 2026	SEC EDGAR
Current report	8-K	Mar 27, 2026	Mar 27, 2026	SEC EDGAR
Current report	8-K	Mar 13, 2026	Mar 13, 2026	SEC EDGAR
Current report	8-K	Mar 5, 2026	Mar 10, 2026	SEC EDGAR
Current report	8-K	Mar 9, 2026	Mar 9, 2026	SEC EDGAR
Current report	8-K	Mar 5, 2026	Mar 5, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 5, 2026	SEC EDGAR
Current report	8-K	Feb 12, 2026	Feb 12, 2026	SEC EDGAR
Current report	8-K	Feb 12, 2026	Feb 12, 2026	SEC EDGAR
Current report	8-K	Feb 5, 2026	Feb 5, 2026	SEC EDGAR
Current report	8-K	Jan 27, 2026	Jan 28, 2026	SEC EDGAR
Current report	8-K	Jan 13, 2026	Jan 15, 2026	SEC EDGAR
Current report	8-K	Jan 12, 2026	Jan 12, 2026	SEC EDGAR
Current report	8-K	Jan 6, 2026	Jan 6, 2026	SEC EDGAR
Current report	8-K	Dec 30, 2025	Dec 31, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Profound Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PROF.

Compare: PROF vs BDMD · PROF vs PLSM · PROF vs FOCL · PROF vs SRTS · PROF vs LNSR

Revenue growth65.3% · median -25.9%

Gross margin73.9% · median 44.2%

Operating margin-145.1% · median -39.5%

Net margin-137.5% · median -16.2%

Company	Revenue	Growth
LNSR	$60.08M	+1.6%
PROF	$23.63M	+65.3%
SRTS	$17.51M	-53.4%
BDMD	–	–
PLSM	–	–
FOCL	–	–

Company

Next earnings (est.): Mar 4, 2027, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 162
Held by institutions: 45.2%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1628808

Advertisement
300 × 250

See a number that looks wrong?